Targeting the human macrophage with combinations of drugs and inhibitors of Ca2+ and K+ transport to enhance the killing of intracellular multi-drug resistant Mycobacterium tuberculosis (MDR-TB) - a novel, patentable approach to limit the emergence of XDR-TB.

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)
Original languageUnknown
Pages (from-to)110-117
JournalRecent Patents On Anti-Infective Drug Discovery
Issue number2
Publication statusPublished - 1 Jan 2011

Cite this